MedTrace Logo

Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors

NCT05282784 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-03-16

No results posted yet for this study

Summary

The main purpose of this study is to evaluate immunogenic effect of hyperthermia applied with flexible electrode-typed 2-MHz device during radiotherapy for solid tumors.

Conditions

Interventions

OTHER

Hyperthermia

Patients will be treated with hyperthermia 2 or 3 times a week. Treatment will be performed for 1 hours per each visit. Patients will be treated with radiotherapy 5 times a week.

RADIATION

Radiotherapy

Patients will be treated with radiotherapy 5 times a week.

Sponsors & Collaborators

  • Medicon, Inc.

    collaborator INDUSTRY

  • Yonsei Hyperthermia Study Group

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-10
Primary Completion
2022-04-30
Completion
2022-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05282784 on ClinicalTrials.gov